Filing Details

Accession Number:
0001808805-22-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-28 16:01:57
Reporting Period:
2022-09-26
Accepted Time:
2022-09-28 16:01:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808805 Nautilus Biotechnology Inc. NAUT Laboratory Analytical Instruments (3826) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856744 Subramanian Sankar C/O Nautilus Biotechnology, Inc.
2701 Eastlake Avenue East
Seattle WA 98102
Senior Vp, Product Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-26 10,000 $2.03 86,250 No 4 P Direct
Common Stock Acquisiton 2022-09-27 5,000 $2.03 91,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average share price of an aggregate total of 10,000 shares purchased in the price range of $2.00 to $2.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
  3. Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.02 to $2.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.